Stefanie Granado, Ph.D. | Head of US Oncology Business Unit | Takeda Oncology

Stefanie Granado, Ph.D., is Head of the US Oncology Business Unit (US OBU) and a member of the Global Oncology Leadership Team. In her role today, Stefanie leads Takeda’s efforts in the US to accelerate our capabilities, culture and commercialization of our medicines with life-transforming potential.

Prior to this role, Stefanie was Head of the EUCAN OBU, growing our business across Europe and Canada. In this position, Stefanie spearheaded growth in ALUNBRIG first line and oversaw the launch of EXKIVITY. She transformed the EUCAN OBU into a digital-first organization, empowering her team to create omnichannel orchestration campaigns, all while cultivating a collaborative culture throughout the region.

At Takeda, Stefanie also served as General Manager, Iberia (Spain & Portugal), and was responsible for the Spanish and Portuguese Country organization, overseeing 240 people and more than 50 products, and drove the region’s integration of the Shire team and portfolio. Stefanie has extensive pharmaceutical, healthcare and management consulting experience and has a proven track record in emerging and developed markets, ranging from rare disease to vaccines and generics, and has lived and worked in Latin America, Spain, Switzerland, West Africa and the US.

Stefanie holds a Master of Arts degree in Anthropology from the University of Basel, Switzerland, and a Ph.D. in Cultural Epidemiology from the Swiss Tropical and Public Health Institute.